About
Leadership
Therapeutic Focus
UbiPro™ Platform
Molecular Glues
PROTAC
Therapeutic Areas
Partnering
The Progenra Advantage
Partnering Opportunities
Investor Relations
Collaborations
Careers
R&D, Biology
R&D, Medicinal Chemistry
News
News
Meetings
Publications
Blog
Progenra and the Frederick National Laboratory for Cancer Research Establish a contractor Cooperative Research and Development Agreement (cCRADA) to Develop KRAS Degraders for Cancer Therapy